CCR5 Expression Influences the Progression of Human Breast Cancer in a p53-dependent Manner
Open Access
- 3 November 2003
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 198 (9), 1381-1389
- https://doi.org/10.1084/jem.20030580
Abstract
Chemokines are implicated in tumor pathogenesis, although it is unclear whether they affect human cancer progression positively or negatively. We found that activation of the chemokine receptor CCR5 regulates p53 transcriptional activity in breast cancer cells through pertussis toxin–, JAK2-, and p38 mitogen–activated protein kinase–dependent mechanisms. CCR5 blockade significantly enhanced proliferation of xenografts from tumor cells bearing wild-type p53, but did not affect proliferation of tumor xenografts bearing a p53 mutation. In parallel, data obtained in a primary breast cancer clinical series showed that disease-free survival was shorter in individuals bearing the CCR5Δ32 allele than in CCR5 wild-type patients, but only for those whose tumors expressed wild-type p53. These findings suggest that CCR5 activity influences human breast cancer progression in a p53-dependent manner.Keywords
This publication has 37 references indexed in Scilit:
- Blocking of HIV-1 Infection by Targeting CD4 to Nonraft Membrane DomainsThe Journal of Experimental Medicine, 2002
- Chemokines: agents for the immunotherapy of cancer?Nature Reviews Immunology, 2002
- Determinants of the trans-Dominant Negative Effect of Truncated Forms of the CCR5 Chemokine ReceptorPublished by Elsevier BV ,2001
- A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell deathCurrent Biology, 2001
- Response of Cell Cycle Proteins to Neurotrophic Factor and Chemokine Stimulation in Human NeurogliaExperimental Neurology, 2001
- Spectrofluorimetric Analysis of CCR5-Δ32 Allele Using Real-Time Polymerase Chain Reaction: Prevalence in Southern Spanish HIV+ Patients and Noninfected PopulationAIDS Research and Human Retroviruses, 2001
- CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritisGenes & Immunity, 2000
- Noncompetitive, Chemokine-mediated Inhibition of Basic Fibroblast Growth Factor-induced Endothelial Cell ProliferationJournal of Biological Chemistry, 1998
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996